[HTML][HTML] Targeted drug delivery strategies for precision medicines

MT Manzari, Y Shamay, H Kiguchi, N Rosen… - Nature Reviews …, 2021 - nature.com
Progress in the field of precision medicine has changed the landscape of cancer therapy.
Precision medicine is propelled by technologies that enable molecular profiling, genomic …

The promise of nanotechnology in personalized medicine

MA Alghamdi, AN Fallica, N Virzì… - Journal of personalized …, 2022 - mdpi.com
Both personalized medicine and nanomedicine are new to medical practice. Nanomedicine
is an application of the advances of nanotechnology in medicine and is being integrated into …

Co-assembly of Ag nanowires and nanocubes mediated by adhesive tape in hydrophilic and hydrophobic pattern for SERS-based determination of gefitinib and …

X Dai, X Liu, T Xu, C Gu, F Zhao, T Jiang - Sensors and Actuators B …, 2023 - Elsevier
Controlled aggregation of noble metal nanoparticles is incredibly crucial for obtaining
reliable surface-enhanced Raman scattering (SERS) properties. Here, a rational …

Amoxicillin functionalized gold nanoparticles reverts MRSA resistance

S Kalita, R Kandimalla, KK Sharma, AC Kataki… - Materials Science and …, 2016 - Elsevier
In this study, we have described the biosynthesis of biocompatible gold nanoparticles
(GNPs) from aqueous extract of the aerial parts of a pteridophyte,“Adiantum philippense” by …

Naked-eye detection of pandemic influenza a (pH1N1) virus by polydiacetylene (PDA)-based paper sensor as a point-of-care diagnostic platform

SU Son, SB Seo, S Jang, J Choi, J Lim, DK Lee… - Sensors and Actuators B …, 2019 - Elsevier
We have developed polydiacetylene (PDA)-based colorimetric biosensor for point-of-care
testing (POCT) to detect high infectious pH1N1 virus among influenza A virus with the naked …

Gefitinib: an updated review of its role in the cancer management, its nanotechnological interventions, recent patents and clinical trials

P Kumar, B Mangla, S Javed, W Ahsan… - Recent patents on …, 2023 - ingentaconnect.com
Background: Gefitinib, a tyrosine kinase inhibitor, is effectively used in the targeted treatment
of malignant conditions. It suppresses the signal transduction cascades leading to cell …

Nanomedicine strategies for management of drug resistance in lung cancer

M Haider, A Elsherbeny, V Pittalà, V Consoli… - International Journal of …, 2022 - mdpi.com
Lung cancer (LC) is one of the leading causes of cancer occurrence and mortality
worldwide. Treatment of patients with advanced and metastatic LC presents a significant …

The potential of multi-compound nanoparticles to bypass drug resistance in cancer

CG Da Silva, GJ Peters, F Ossendorp… - Cancer chemotherapy and …, 2017 - Springer
Purpose The therapeutic efficacy of conventional chemotherapy against several solid tumors
is generally limited and this is often due to the development of resistance or poor delivery of …

Impact of alkyl chain length and water on the structure and properties of 1-alkyl-3-methylimidazolium chloride ionic liquids

P Sanchora, DK Pandey, HL Kagdada… - Physical Chemistry …, 2020 - pubs.rsc.org
The influence of the length of the alkyl chain and water molecules on the hydrogen-bond
interaction of the chloride anion and imidazolium-based cation of the ionic liquid (IL) Cnmim …

[HTML][HTML] Nanomedicine of tyrosine kinase inhibitors

V Smidova, P Michalek, Z Goliasova, T Eckschlager… - Theranostics, 2021 - ncbi.nlm.nih.gov
Recent progress in nanomedicine and targeted therapy brings new breeze into the field of
therapeutic applications of tyrosine kinase inhibitors (TKIs). These drugs are known for many …